Immunosuppressive Drug Therapies Flashcards

(40 cards)

1
Q

clinical approach to immune mediated disease

A
  1. confirm diagnosis of immune mediated disease (primary vs secondary)
  2. client education and communication
  3. rational application of immunosuppressive therapy
  4. active monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why is confirmation of diagnosis important prior to treatment

A

therapy is immunosuppressive - if animal has an infection then disease will get worse

must differentiate primary vs secondary because need to treat underlying disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why is client education important

A

long term treatment required
can be expensive
medications have side effects
risk if underlying cause is infectious or neoplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

guidelines for immunosuppressive therapy

A
  1. avoid excessive immunosuppression
  2. never use more than 2 immunosuppressive drugs at a time
  3. want to pulse immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

goal of active monitoring

A

assess remission using an objective measure

balance efficacy of drug with adverse side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

goal for duration of treatment

A

<6 months

taper by 25% at each check in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is considered successful therapy

A

remission of disease with gradual taper of medications over 3 months with minimal adverse effects

if starting to show signs of disease during tapering - go back up and stay at therapeutic dosing for longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is considered a therapeutic failure

A
  1. inadequate response to treatment
  2. multiple relapses
  3. drug adverse reactions
  4. opportunistic infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

types of immunosuppressive drugs

A
  1. glucocorticoids
  2. cyclosporine A
  3. azathioprine
  4. chloramphenicol
  5. mycophenolate
  6. leflunomide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

glucocorticoids

A

VERY effective - 1st choice
has HIGH adverse effects that WILL happen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

glucocorticoid drugs

A

prednisone
prednisolone
dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

glucocorticoid dosing

A

depends on drug and disease being treated
1. physiologic - low dose
2. anti-inflammatory - medium dose
3. immunosuppressive - extremely high dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the maximum dose for glucocorticoids

A

60-80 mg total per day REGARDLESS of dog size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

glucocorticoid MOA

A

inhibits phospholipase A2 –> decreases prostaglandin, leukotriene, and thromboxane production

BROAD immunosuppression - inhibits many parts of the immune response (innate and adaptive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what should glucocorticoids never be used in combination with

A

NSAIDs

will completely inhibit prostaglandin pathway –> damage to mucosa –> GI ulceration and perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

glucocorticoid adverse effects

A
  • PU/PD/PP
  • panting
  • muscle wasting
  • GI ulceration
  • potbelly appearance
  • “pred head”
  • alopecia
  • thin skin
  • decreased hair growth
  • calcinosis cutis
  • behavioral changes
  • opportunistic infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

cyclosporine A

A

2nd most common immunosuppressant

18
Q

cyclosporine A dosing

A

increased dose beyond that labeled for atopic dermatitis

19
Q

cyclosporine A MOA

A

calcineurin inhibitor

interacts with cyclophilins in lymphocytes –> blocks transcription factors for interleukin 2 –> down regulation of T cell proliferation and activation

SPECIFIC immunosuppressant - inhibits T cell expansion

20
Q

cyclosporine A adverse effects

A

GI signs - vomiting, diarrhea
gingival hyperplasia
dermatopathies
hepato and nephrotoxicity

21
Q

cyclosporine A drug interactions

A

cyclosporine A is a p450 enzyme substrate

concentration increased by azole antifungals, metocomplramide, macrolides, fluoroquinolones, omeprazole

22
Q

azathioprine MOA

A

targets rapidly dividing cells - T cells, B cells, intestinal epithelial cells, bone marrow

delayed onset of action - often used in conjunction with glucocorticoids

23
Q

azathioprine adverse effects

A

dogs: BM suppression, hepatotoxicity

cats: do NOT use in cats

24
Q

chlorambucil

A

used in CATS

very safe - few adverse effects

25
mycophenolate
first choice for immune mediated glomerulonephritis second choice for refractory IMHA, IMPA
26
mycophenolate MOA
inhibits purine synthesis targets rapidly dividing cells (lymphocytes)
27
mycophenolate adverse effects
profound GI toxicity
28
leflunomide
backup drug for refractory IMPA inhibits pyrimidine synthesis targets rapidly dividing cells
29
therapeutic plasma exchange
removes serum of dogs with immune disease --> replacing with donor serum that lacks autoantibodies used for severe, life threatening conditions (ex. IMHA)
30
immune mediated hemolytic anemia (IMHA)
type 2 hypersensitivity - antibody mediated destruction of red blood cells
31
characteristics of IMHA
regenerative anemia agglutination of RBCs spherocytosis hemolysis - hyperbilirubinemia, hemolyzed serum coomb's test - detects antibodies against RBCs
32
treatment of IMHA
prednisone clopidogrel - thromboprophylaxis
33
immune mediated glomerulonephritis
immune complex (IgG) deposition within nephrons
34
IMG characteristics
profound proteinuria - protein losing nephropathy renal azotemia hypoalbuminemia
35
IMG treatment
plasma exchange hemodialysis corticosteroids mycophenolate
36
immune mediated polyarthritis (IMPA)
type III hypersensitivity reaction - immune complex deposition into the joint space --> activates complement --> local inflammation
37
diagnosis of IMPA
arthrocentesis in 3+ joints carpus, tarsus, stifle
38
IMPA treatment
prednisone
39
polyarthritis syndromes
IMPA + additional immune disease polymyositis, meningitis
40
immune mediated thrombocytopenia (IMTP)
antibody mediated destruction of platelets primary coagulopathy severe thrombocytopenia tx: prednisone